Hypersensitivity to mycophenolate mofetil in systemic lupus erythematosus: Diagnostic measures and successful desensitization

International Archives of Allergy and Immunology

Volumn 138, Issue 4, 2005, Pages 334-336

  Szyper Kravitz, Martine ^a   Sheinberg, Pavel ^a   Sidi, Yechezkel ^a   Schiffenbauer, Yael ^a   Trubniykov, Ela ^a   Shoenfeld, Yehuda ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Desensitization; Mycophenolate mofetil; Systemic lupus erythematosus

Indexed keywords

ANTIHISTAMINIC AGENT; CALCIUM; CLINDAMYCIN; FAMOTIDINE; HYDROXYCHLOROQUINE; IMIPRAMINE; LEVOTHYROXINE; MORPHINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OFLOXACIN; PREDNISONE; VITAMIN D;

ADULT; ARTICLE; BLOOD SAMPLING; CASE REPORT; DESENSITIZATION; DRUG HYPERSENSITIVITY; DRUG TOLERANCE; FEMALE; HUMAN; INFECTION; LEG ULCER; NEUROPATHIC PAIN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; URTICARIA; VITAMIN SUPPLEMENTATION;

DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MYCOPHENOLIC ACID; URTICARIA;

EID: 27844592289     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088873     Document Type: Article

References (25)

1. Zandman-Goddad G, Shoenfeld Y: Novel approaches to therapy for systemic lupus erythematosus. Eur J Int Med 2000;11:130-134.
2. Goldblum R: Therapy of rheumatoid arthritis with mycophenolate mofetil. Clin Exp Rheumatol 1993;11(suppl 8):S117-S119.
3. Nowack R, Gobel U, Klooker P, Hergesell O, Andrassy K, van der Woude FJ: Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol 1999;10:1965-1971.
4. Zimmer-Molsberger B, Knauf W, Thiel E: Mycophenolate mofetil for severe autoimmune hemolytic anemia. Lancet 1997;350:1003-1004.
5. Chan TM, Li FK, Tang CS, et al: Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guanazhou Nephrology Study Group. N Engl J Med 2000;34:1156-1162.
6. Contreras G, Pardo V, Leclercq B, et al: Sequential therapies for proliferative lupus nephritis. N Engl J Med 2004;350:971-980.
7. Kingdon EJ, McLean AG, Psimenou E, et al: The safety and efficacy of MMF in lupus nephritis: a pilot study. Lupus 2001;10:606-611.
8. Adu D, Cross J, Jayne DRW: Treatment of systemic lupus erythematosus with mycophenolate mofetil. Lupus 2001;10:203-208.
9. Kapitsinou PP, Boletis JN, Skopouli FN, Boki KA, Moutspoulos HM: Lupus nephritis: treatment with mycophenolate mofetil. Rheumatology 2004;43:377-380.
10. Moder KG: Mycophenolate mofetil: new applications for this immunosuppressant. Ann Allergy Asthma Immunol 2003;90:15-19.
11. Alba P, Karim MY, Hunt BJ: Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lupus 2003;12:633-635.
12. Karim MY, Alba P, Cuadrado MJ, Abbs IC, D'Cruz DP, Khamashta MA, Hughes GRV: Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology 2002;41:876-882.
13. Goldberg I, Gilburd B, Kravitz Ms, et al: A novel system to diagnose cutaneous adverse drug reactions employing the cellscan - Comparison with histamine release test and INF-γ releasing test. A preliminary report. Clin Dev Immunol 2005;12:85-90.
14. Shoenfeld Y, Livni E, Shaklai M, Pinkhas J: Sensitization to ibuprofen in systemic lupus erythematosus. JAMA 1980;244:547-548.
15. Petri M, Allbritton J: Antibiotic allergy in systemic lupus erythematosus: a case-control study. J Rheumatol 1992;19:265-269.
16. Sequeira JF, Cesic D, Keser G, et al: Allergic disorders in systemic lupus erythematosus. Lupus 1993;2:187-191.
17. Elkayam O, Tamir R, Pick AI, Wysenbeek A: Serum IgE concentration, disease activity, and atopic diseases in systemic lupus erythematosus. Allergy 1995;50:94-96.
18. Pope J, Jerome D, Fenlon D, Krizova A, Ouimet J: Frequency of adverse drug reactions in patients with systemic lupus erythematosus. J Rheumatol 2003;30:480-484.
19. Becker LC: Allergy in systemic lupus erythematosus. Johns Hopkins Med J 1973;133:38-44.
20. Von Maur K, Turk A, Stevens MB, Adkinson NF, Lichtenstein LM: Penicillin hypersensitivity in systemic lupus erythematosus. Int Allergy Appl Immunol 1975;49:428-433.
21. Wang CR, Chuang CY, Chen CY, Petri M, Allbritton J: Drug allergy in Chinese patients with systemic lupus erythematosus. J Rheumatol 1993;20:399-400.
22. Morton S, Palmer B, Muir K, Powell RJ: IgE and non-IgE mediated allergic disorders in systemic lupus erythematosus. Ann Rheum Dis 1998;57:660-663.
23. Cellcept (mycophenolate mofetil). Complete product information. Roche Laboratories Inc. revised March 2003.
24. Riskalla M, Somers EC, Fatica RA, McCune WJ: Tolerabity of mycophenolate mofetil in patients with systemic lupus erythematosus. J Rheumatol 2003;30:1508-1512.
25. Adkinson NK: Drug allergy; in Adkinson NK, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simmons ER (eds): Middleton's Allergy: Principles and Practice. Philadelphia, Mosby, 2003, pp 1679-1694.